These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18030789)

  • 1. [Moxifloxacin clinical and microbiological efficacy in therapy of infectious endocarditis].
    Beloborodova NV; Popov DA; Bachinskaia EN; Sedrakian AR; Vostrikova TIu
    Antibiot Khimioter; 2006; 51(9-10):33-9. PubMed ID: 18030789
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Staphylococcus aureus endocarditis using moxifloxacin.
    Berrington AW; Koerner RJ; Perry JD; Bain HH; Gould FK
    Int J Med Microbiol; 2001 Aug; 291(3):237-9. PubMed ID: 11554565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stenotrophomonas maltophilia endocarditis treated with moxifloxacin-ceftazidime combination and annular wrapping technique.
    Sanioğlu S; Sokullu O; Yavuz SS; Kut MS; Palaz FK; Bilgen FS
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):79-80. PubMed ID: 18258545
    [No Abstract]   [Full Text] [Related]  

  • 4. [Investigation of moxifloxacin, a new antimicrobial of the fluoroquinolone group in Russia].
    Iakovlev VS; Iakovlev VP
    Antibiot Khimioter; 2007; 52(6):28-35. PubMed ID: 18476472
    [No Abstract]   [Full Text] [Related]  

  • 5. Moxifloxacin-dependent Torsades de Pointes.
    Tiryakioğlu SK; Tiryakioğlu O; Aktürk F; Mehmetoğlu E; Kumbay E
    Anadolu Kardiyol Derg; 2011 Sep; 11(6):560-2. PubMed ID: 21827995
    [No Abstract]   [Full Text] [Related]  

  • 6. Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.
    Skiadas I; Pefanis A; Papalois A; Kyroudi A; Triantafyllidi H; Tsaganos T; Giamarellou H
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2848-54. PubMed ID: 17562794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abstracts of the 6th Moxifloxacin Research Workshop, March 1-2, 2007, Leverkusen, Germany].
    Infection; 2007 Aug; 35 Suppl 1():i-x, 4-73. PubMed ID: 18183639
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nongonococcal urethritis treatment in men with avelox (moxifloxacin)].
    Aboian IA; Pavlov SV; Miroshnichenko VI; Shestel' AN
    Urologiia; 2007; (1):49-52. PubMed ID: 17472000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abstracts of 8th Moxifloxacin Research Workshop. November 17-18, 2012. Leverkusen, Germany].
    Infection; 2012 Aug; 40 Suppl 1():1-71. PubMed ID: 22936293
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacodynamic profile and clinical efficacy of moxifloxacin ophthalmic solution (Vegamox 0.5% ophthalmic solution].
    Watanabe M; Ishizuka K; Ikemoto T
    Nihon Yakurigaku Zasshi; 2007 May; 129(5):375-85. PubMed ID: 17507775
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.
    Join-Lambert O; Coignard H; Jais JP; Guet-Revillet H; Poirée S; Fraitag S; Jullien V; Ribadeau-Dumas F; Thèze J; Le Guern AS; Behillil S; Leflèche A; Berche P; Consigny PH; Lortholary O; Nassif X; Nassif A
    Dermatology; 2011 Feb; 222(1):49-58. PubMed ID: 21109728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based review of moxifloxacin.
    O'Brien TP
    Int Ophthalmol Clin; 2006; 46(4):61-72. PubMed ID: 17060792
    [No Abstract]   [Full Text] [Related]  

  • 13. Moxifloxacin-induced hypoglycemia in a non-diabetic patient.
    Mandavia DR; Virpariya MM; Patel TK; Tripathi CB
    Curr Drug Saf; 2012 Apr; 7(2):183-5. PubMed ID: 22873504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Points: tachycardia associated with moxifloxacin.
    Siepmann M; Kirch W
    BMJ; 2001 Jan; 322(7277):23. PubMed ID: 11141146
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
    van Nieuwkoop C; Visser LG; Groeneveld JH; Kuijper EJ
    J Infect; 2008 Feb; 56(2):155-6. PubMed ID: 18083235
    [No Abstract]   [Full Text] [Related]  

  • 16. Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study.
    Zhou B; Jiang X; Zhai L; Xiao S; Wang J; Xiao G; Ruan B; Liang C; Ye Q; Hu B; Wang H
    Acta Otolaryngol; 2010 Sep; 130(9):1058-64. PubMed ID: 20235900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].
    Bschleipfer T; Wagenlehner FM; Weidner W
    Urologe A; 2007 Sep; 46(9):1027-30. PubMed ID: 17593342
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience in using the new drug moxifloxacin (Avelox, "Bayer", Germaniia) in urologic practice].
    Derevianko II
    Urologiia; 2003; (3):24-6. PubMed ID: 12846092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cure of Q fever pneumonia with moxifloxacin: case report.
    Kuzman I; Puljiz I; Ethaković-Rode O
    Scand J Infect Dis; 2005; 37(10):778-80. PubMed ID: 16191902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fourth-generation fluoroquinolones in tuberculosis.
    Rieder HL
    Lancet; 2009 Apr; 373(9670):1148-9. PubMed ID: 19345815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.